BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNMT1
,
Metabolism of xenobiotics
,
Arthritis
,
Leukocyte
,
Biofuel
,
Tamoxifen
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lymphoma non hodgkin
Summary
General Info
Curated Studies
Most Correlated Studies
Canine lymphomas analyzed by breed and subtype
Lymphoma (4 types) and B-cell purified subpopulation gene expression profiling
EZH2 mutant and wild type DLBCL cell lines treated with a EZH2 inhibitor
MALT lymphoma gene expression profiling from samples with or without translocations
Myeloma versus other lymphoma cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma.
Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
Management of vaccinations in patients with non-Hodgkin lymphoma.
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clini…
Acute kidney failure reveals primary renal non-Hodgkin lymphoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or N…
Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non…
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Othe…
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's …
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ